Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses

Contributed by: PR Newswire

Tags

BIORETEC-Review

More Like This

Bioretec Ltd's half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results

Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory

Bioretec Ltd's business review January-September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage

Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth in 2024 - CE mark received in January 2025

Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy

Bioretec Ltd's Annual Report 2024 published

Bioretec Ltd's Annual Report and Financial Statements 2023 published

Bioretec Ltd's Financial Statements 2024 published